Metformin Teva

Metformin, the active ingredient in Metformin Teva, is a biguanide presented as a tablet for oral use. It reduces hepatic glucose production and improves peripheral insulin sensitivity, helping to control elevated blood glucose levels in adults diagnosed with type 2 diabetes mellitus as part of a broader therapeutic regimen.

GNH USA supplies Metformin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing EU‑sourced product that meets stringent quality standards for global distribution.

Metformin Teva is indicated for conditions related to abnormal glucose metabolism. - Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose. - Impaired glucose tolerance: delays progression to overt diabetes when combined with lifestyle measures. - Polycystic ovary syndrome: reduces insulin resistance and may improve menstrual regularity.

Metformin may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea. - Metallic taste: transient alteration in taste perception. - Vitamin B12 deficiency: reduced absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe hypoglycemia: usually when combined with other glucose‑lowering agents. - Hepatotoxicity: uncommon liver enzyme elevation.

When prescribing Metformin Teva, clinicians should consider several safety precautions to minimize risk. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment. - Alcohol consumption: limit intake as it may increase acidosis risk. - Pregnancy and lactation: evaluate benefits versus risks with obstetric guidance. - Drug interactions: review concomitant medications that affect renal clearance. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture.

Metformin Teva can interact with other medicines, influencing its plasma concentration or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate renal dysfunction and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma levels, enhancing toxicity. - Chronic alcohol abuse: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics (thiazides): can affect renal clearance and electrolyte balance. - ACE inhibitors or ARBs: require monitoring of renal function and lactic acidosis signs.